HealthyWomen recently hosted a congressional briefing exploring the importance and current challenges of including women of reproductive age in clinical trials. View the recording below to gain a greater understanding of the requirements women must meet to participate in a clinical trial and how those guidelines have become more complicated with new state reproductive health laws in place, especially as participation recruitment relates to meeting diversity and inclusion goals. Panelists highlighted the importance of increasing clinical trials that focus on maternal health, specifically the study of pregnant and lactating women.
Moderator: Marsha Henderson, Former Associate Commissioner for Women’s Health, FDA
Lois J. Frankel
U.S. Representative, D-F.L.
Ramita Tandon, Chief Clinical Trials Officer, Walgreens Health
Diana W. Bianchi, M.D., Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Rebecca Abbott, Director of Government Relations, Society for Maternal-Fetal Medicine
Kay Matthews, LCHW, Founder, Shades of Blue Project